How can clinical researchers quantify the value of their proposed comparative research?

[1]  David D. Kim,et al.  Integrating value of research into NCI Clinical Trials Cooperative Group research review and prioritization: A pilot study , 2018, Cancer medicine.

[2]  D. Meltzer,et al.  Decision Criterion and Value of Information Analysis: Optimal Aspirin Dosage for Secondary Prevention of Cardiovascular Events , 2018, Medical decision making : an international journal of the Society for Medical Decision Making.

[3]  J. Coast,et al.  Interpretation of the Expected Value of Perfect Information and Research Recommendations , 2016, Medical decision making : an international journal of the Society for Medical Decision Making.

[4]  S. Ramsey,et al.  Development and Evaluation of an Approach to Using Value of Information Analyses for Real-Time Prioritization Decisions Within SWOG, a Large Cancer Clinical Trials Cooperative Group , 2016, Medical decision making : an international journal of the Society for Medical Decision Making.

[5]  B. Zinman,et al.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. , 2015, The New England journal of medicine.

[6]  J. Manson,et al.  Economic Return From the Women's Health Initiative Estrogen Plus Progestin Clinical Trial , 2014, Annals of Internal Medicine.

[7]  Rahber Thariani,et al.  Value-of-Information Analysis within a Stakeholder-Driven Research Prioritization Process in a US Setting: An Application in Cancer Genomics , 2013, Medical decision making : an international journal of the Society for Medical Decision Making.

[8]  G. Stone,et al.  Safety and efficacy of high- versus low-dose aspirin after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. , 2012, JACC. Cardiovascular interventions.

[9]  Anke J. E. de Veer,et al.  Factors influencing the implementation of clinical guidelines for health care professionals: A systematic meta-review , 2008, BMC Medical Informatics Decis. Mak..

[10]  V. Hasselblad,et al.  Seeking the optimal aspirin dose in acute coronary syndromes. , 2002, The American journal of cardiology.

[11]  Catherine Sudlow,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[12]  Walker,et al.  Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .

[13]  B. Freedman.  Equipoise and the ethics of clinical research. , 1987, The New England journal of medicine.

[14]  M. Sculpher,et al.  Using Value of Information Analysis to Prioritise Health Research , 2012, PharmacoEconomics.